Obstet Gynecol Sci.  2014 Nov;57(6):513-517. 10.5468/ogs.2014.57.6.513.

Prevalence of thromogenic gene mutations in women with recurrent miscarriage: A retrospective study of 1,507 patients

• Incebiyik
• Hilali NG
• Camuzcuoglu A
• Camuzcuoglu H
• Akbas H
• Kilic A
• Vural M

• KMID: 2314019
• DOI: http://doi.org/10.5468/ogs.2014.57.6.513

Abstract

OBJECTIVE
Thromogenic gene mutations has been thought to be associated with recurrent pregnancy loss in women in Turkey. The aim of this study was to investigate the prevalence of thromogenic gene mutations such as factor V Leiden (FVL, G1691T), prothrombin (G20210A), and the methylene tetrahydrofolate reductase (MTHFR, C677T) mutation in women with recurrent pregnancy loss.
METHODS
This descriptive study was carried out in the Department of Obstetrics and Gynaecology, Harran University School of Medicine, and included a total of 1,507 women with histories of recurrent pregnancy loss between January 2010 and June 2013. The mutations were assessed by using the polymerase chain reaction.
RESULTS
The homozygous mutation frequencies of FVL, prothrombin, and MTHFR were found to be 3 (0.20%), 0 and 125 (8.29%), and the heterozygous mutation frequencies were 83 (5.51%), 61 (4.05%), and 612 (40.61%), respectively. Among the 86 FVL mutation patients, 38 also had accompanying prothrombin and MTHFR mutations.
CONCLUSION
Since the homozygous forms of the FVL-prothrombin gene mutations have low incidences and MTHFR mutation is similar to a healthy population, preconceptional thromogenic gene mutations screening seems to be controversial.

Keyword

Factor V Leiden; Methylenetetrahydrofolate reductas; Prevalence; Prothrombin; Recurrent pregnancy loss

MeSH Terms

Abortion, Habitual*
Factor V
Female
Humans
Incidence
Mass Screening
Methylenetetrahydrofolate Reductase (NADPH2)
Mutation Rate
Obstetrics
Polymerase Chain Reaction
Pregnancy
Prevalence*
Prothrombin
Retrospective Studies*
Turkey
Factor V
Methylenetetrahydrofolate Reductase (NADPH2)
Prothrombin

Reference

1. Hossain N, Shamsi T, Khan N, Naz A. Thrombophilia investigation in Pakistani women with recurrent pregnancy loss. J Obstet Gynaecol Res. 2013; 39:121–125.

2. Cao Y, Xu J, Zhang Z, Huang X, Zhang A, Wang J, et al. Association study between methylenetetrahydrofolate reductase polymorphisms and unexplained recurrent pregnancy loss: a meta-analysis. Gene. 2013; 514:105–111.

3. Teremmahi Ardestani M, Nodushan HH, Aflatoonian A, Ghasemi N, Sheikhha MH. Case control study of the factor V Leiden and factor II G20210A mutation frequency in women with recurrent pregnancy loss. Iran J Reprod Med. 2013; 11:61–64.

4. Martínez-Zamora MÁ, Cervera R, Balasch J. Recurrent miscarriage, antiphospholipid antibodies and the risk of thromboembolic disease. Clin Rev Allergy Immunol. 2012; 43:265–274.

5. Vora S, Shetty S, Ghosh K. Thrombophilic dimension of recurrent fetal loss in Indian patients. Blood Coagul Fibrinolysis. 2008; 19:581–584.

6. Ferroni P, La Farina F, Palmirotta R, Martini F, Raparelli V, Nigro C, et al. Predictive value of thrombopath determination in women with infertility and pregnancy complications. Clin Chim Acta. 2010; 411:37–42.

7. Ayadurai T, Muniandy S, Omar SZ. Thrombophilia investigation in Malaysian women with recurrent pregnancy loss. J Obstet Gynaecol Res. 2009; 35:1061–1068.

8. Middeldorp S. Pregnancy failure and heritable thrombophilia. Semin Hematol. 2007; 44:93–97.

9. Kabukcu S, Keskin N, Keskin A, Atalay E. The frequency of factor V Leiden and concomitance of factor V Leiden with prothrombin G20210A mutation and methylene tetrahydrofolate reductase C677T gene mutation in healthy population of Denizli, Aegean region of Turkey. Clin Appl Thromb Hemost. 2007; 13:166–171.

10. McNamee K, Dawood F, Farquharson RG. Thrombophilia and early pregnancy loss. Best Pract Res Clin Obstet Gynaecol. 2012; 26:91–102.

11. Akar N. Factor V 1691 G-A mutation distribution in a healthy Turkish population. Turk J Haematol. 2009; 26:9–11.

12. Vurkun M, Vural O, Demir M, Turgut B, Gurgey A, Parlak H, et al. The Prevalence of activated protein C resistance and F V leiden in healthy population of edirne, Turkey. Turk J Haematol. 2002; 19:287–291.

13. Irdem A, Devecioglu C, Batun S, Soker M, Sucakli IA. Prevalence of factor V Leiden and prothrombin G20210A gene mutation. Saudi Med J. 2005; 26:580–583.

14. Behjati R, Modarressi MH, Jeddi-Tehrani M, Dokoohaki P, Ghasemi J, Zarnani AH, et al. Thrombophilic mutations in Iranian patients with infertility and recurrent spontaneous abortion. Ann Hematol. 2006; 85:268–271.

15. Ayyildiz O, Kalkanli S, Batun S, Aybak M, Isikdogan A, Tiftik N, et al. Prothrombin G20210A gene mutation with LightCycler polymerase chain reaction in venous thrombosis and healthy population in the southeast of Turkey. Heart Vessels. 2004; 19:164–166.

16. Altintas A, Pasa S, Akdeniz N, Cil T, Yurt M, Ayyildiz O, et al. Factor V Leiden and G20210A prothrombin mutations in patients with recurrent pregnancy loss: data from the southeast of Turkey. Ann Hematol. 2007; 86:727–731.

17. Callejon G, Mayor-Olea A, Jimenez AJ, Gaitan MJ, Palomares AR, Martinez F, et al. Genotypes of the C677T and A1298C polymorphisms of the MTHFR gene as a cause of human spontaneous embryo loss. Hum Reprod. 2007; 22:3249–3254.

18. Sazci A, Ergul E, Kaya G, Kara I. Genotype and allele frequencies of the polymorphic methylenetetrahydrofolate reductase gene in Turkey. Cell Biochem Funct. 2005; 23:51–54.

19. Yildiz G, Yavuzcan A, Yildiz P, Süer N, Tandogan N. Inherited thrombophilia with recurrent pregnancy loss in Turkish women: a real phenomenon? Ginekol Pol. 2012; 83:598–603.

20. Biswas A, Choudhry P, Mittal A, Meena A, Ranjan R, Choudhry VP, et al. Recurrent abortions in Asian Indians: no role of factor V Leiden Hong Kong/Cambridge mutation and MTHFR polymorphism. Clin Appl Thromb Hemost. 2008; 14:102–104.

21. Rodger MA, Paidas M, McLintock C, Middeldorp S, Kahn S, Martinelli I, et al. Inherited thrombophilia and pregnancy complications revisited. Obstet Gynecol. 2008; 112(2 Pt 1):320–324.

22. Carp H, Dolitzky M, Tur-Kaspa I, Inbal A. Hereditary thrombophilias are not associated with a decreased live birth rate in women with recurrent miscarriage. Fertil Steril. 2002; 78:58–62.

23. Gris JC. Thrombophilia and pregnancy loss: cause or association. Thromb Res. 2009; 123:Suppl 2. S105–S110.

24. Bradley LA, Palomaki GE, Bienstock J, Varga E, Scott JA. Can Factor V Leiden and prothrombin G20210A testing in women with recurrent pregnancy loss result in improved pregnancy outcomes?: results from a targeted evidence-based review. Genet Med. 2012; 14:39–50.

25. American College of Obstetricians and Gynecologists Committee on Practice Bulletins-Obstetrics. ACOG Practice Bulletin No. 111: inherited thrombophilias in pregnancy. Obstet Gynecol. 2010; 115:877–887.

26. Wu O, Robertson L, Twaddle S, Lowe GD, Clark P, Greaves M, et al. Screening for thrombophilia in high-risk situations: systematic review and cost-effectiveness analysis. The Thrombosis: Risk and Economic Assessment of Thrombophilia Screening (TREATS) study. Health Technol Assess. 2006; 10:1–110.